Archivos suplementarios
Palabras clave
Fármaco
Perioperatorio
Reacción adversa a medicamentos
Inmunología
Cómo citar
Plaudit
Resumen
Las reacciones a medicamentos pueden ocurrir por mecanismos mediados o no por imunoglobulina E. La alergia a fármacos es un tipo de interacción adversa y comprende una gama de reacciones de hipersensibilidad mediadas por distintos mecanismos inmunológicos con diversas manifestaciones clínicas. Se estima una tasa anual de 3.2 casos fatales de anafilaxia asociados con los fármacos por cada 100 000 habitantes, que parece ser aproximadamente 10 veces mayor en los pacientes hospitalizados. La incidencia de reacciones anafilácticas perioperatorias se estima en uno de cada 10 000-20 000 procedimientos anestésicos. El diagnóstico se basa en una cuidadosa historia clínica y en el examen físico. En algunos casos pueden requerirse pruebas cutáneas, pruebas de retos progresivos y procedimientos de inducción de tolerancia al medicamento. En los pacientes hospitalizados y en el intervalo perioperatorio frecuentemente se emplean relajantes musculares, neurolépticos y morfinomiméticos, por lo que pueden presentarse respuestas adversas a estos fármacos. En esta revisión se hace énfasis en las reacciones alérgicas a los medicamentos y se abordan estrategias para su diagnóstico y manejo.Referencias
Warrington R, Silviu F, Wong T. Drug allergy. Allergy Asthma Clin Immunol. 2018;14(Suppl 2):60. DOI: 10.1186/s13223-018-0289-y
Khan D, Solensky R. Drug allergy. J Allergy Clin Immunol. 2010;125(Suppl 2):S126-S137. DOI: 10.1016/j.jaci.2009.10.028
Fontenot A, Peebles R. Allergy and hypersensitivity. Curr Opin Immunol. 2013;25(6):736-737. DOI: 10.1016/j.coi.2013.10.007
Armentia A, Pineda F, Palacios R, Martín-Gil FJ, Miguel AS, Arenal JJ, et al. Utility of opium seed extract tests in preventing hypersensitivity reactions during surgery. Allergol Immunopathol (Madr). 2014;42(1):56-63. DOI: 10.1016/j.aller.2012.08.010
Pedersen A, Green S, Rose M. Failure to investigate anaesthetic anaphylaxis resulting in a preventable second anaphylactic reaction. Anaesth Intensive Care. 2012;40(6):1053-1055. DOI: 10.1177/0310057X1204000619
Plaud B. A new option for the treatment of anaphylaxis linked to steroidal neuromuscular blockers: how much value should we grant to case reports? Can J Anesth. 2014;61(6):511-518. DOI: 10.1007/s12630-014-0150-9
Savic L, Wood P, Savic S. Anaphylaxis associated with general anaesthesia: challenges and recent advances. Trends Anaesth Crit Care. 2012;2(6):258-263. DOI: 10.1016/j.tacc.2012.08.003
Trautmann A, Seidl C, Stoevesandt J, Seitz CS. General anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy. 2016;46(1):125-132. DOI: 10.1111/cea.12632
Adriaensens I, Vercauteren M, Soetens F, Janssen L, Leysen J, Ebo D. Allergic reactions during labour analgesia and caesarean section anaesthesia. Int J Obstet Anesth. 2013;22(3):231-242. DOI: 10.1016/j.ijoa.2013.04.010
Brockow K, Garvey L, Aberer W, Atanaskovic-Markovic M, Barbaud A, Bilo MB, et al. Skin test concentrations for systemically administered drugs: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2013;68(6):702-712. DOI: 10.1111/all.12142
Mirone C, Preziosi D, Mascheri A, Micarelli G, Farioli L, Balossi LG, et al. Identification of risk factors of severe hypersensitivity reactions in general anaesthesia. Clin Mol Allergy. 2015;13(1):11. DOI: 10.1186/s12948-015-0017-9
Muraro A, Roberts G, Worm M, Bilò MB, Brockow K, Fernánde-Rivas M, et al. Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology. Allergy. 2014;69(8):1026-1045. DOI: 10.1111/all.12437
Dong S, Acouetey D, Guéant-Rodriguez RM, Zmirou-Navier D, Rémen T, Blanca M, et al. Prevalence of IgE against neuromuscular blocking agents in hairdressers and bakers. Clin Exp Allergy. 2013;43(11):1256-1262. DOI: 10.1111/cea.12189
Rouzaire P, Nosbaum A, Mullet C, Diot N, Dubost R, Bienvenu F, et al. Immediate allergic hypersensitivity to quinolones associates with neuromuscular blocking agent sensitization. J Allergy Clin Immunol Pract. 2013;1(3):273-279. DOI: 10.1016/j.jaip.2013.02.007.
Galvão V, Giavina-Bianchi P, Castells M. Perioperative anaphylaxis. Curr Allergy Asthma Rep. 2014;14(8):452. DOI: 10.1007/s11882-014-0452-6
Moitra V, Gabrielli A, MacCioli G, O’Connor MF. Anesthesia advanced circulatory life support. Can J Anesth. 2012;59(6):586-603. DOI: 10.1007/s12630-012-9699-3
Harris M, Chung F. Complications of general anesthesia. Clin Plast Surg. 2013;40(4):503-513. DOI: 10.1016/j.cps.2013.07.001
Beggs A, McCann J, Powers J. Delayed-onset malignant hyperthermia in association with rocuronium use. Am J Heal Pharm. 2012;69(13):1128-1134. DOI: 10.2146/ajhp110306
Dewachter P, Mouton-Faivre C, Hepner DL. Perioperative anaphylaxis: what should be known? Curr Allergy Asthma Rep. 2015;15(5):21. DOI: 10.1007/s11882-015-0522-4
Mayorga C, Celiik G, Rouzaire P, Whitaker P, Bonadonna P, Caubet JC, et al. In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper. Allergy. 2016;71(8):1103-1134. DOI: 10.1111/aII.12886.
Ewan P, Dugué P, Mirakian R, Dixon TA, Harper JN, Nasser SM, et al. BSACI guidelines for the investigation of suspected anaphylaxis during general anaesthesia. Clin Exp Allergy. 2010;40(1):15-31. DOI: 10.1111/j.1365-2222.2009.03404.x
Kannan JA, Bernstein JA. Perioperative anaphylaxis: diagnosis, evaluation, and management. Immunol Allergy Clin North Am. 2015;35(2):321-334. DOI: 10.1016/j.iac.2015.01.002
Tamayo E, Rodríguez-Ceron G, Gómez-Herreras J, Fernández A, Castrodeza J, Álvarez FJ. Prick-test evaluation to anaesthetics in patients attending a general allergy clinic. Eur J Anaesthesiol. 2006;23(12):1031-1036. DOI: 10.1017/S0265021506000937
Antunes J, Kochuyt A, Ceuppens JL. Perioperative allergic reactions: experience in a Flemish referral centre. Allergol Immunopathol (Madr). 2014;42(4):348-354. DOI: 10.1016/j.aller.2013.08.001
Harper N, Dixon T, Dugué P, Fay A, Herriot R, Hunter JM, et al. Anaphylactic reactions associated with anaesthesia. Anaesthesia. 2010;11(10):391-393. DOI: 10.1111/j.1365-2044.2008.05733.x
Hagau N, Gherman N, Sfichi M, Petrisor C. Threshold for basophil activation test positivity in neuromuscular blocking agents hypersensitivity reactions. Allergy Asthma Clin Immunol. 2013;9(1):42. DOI: 10.1186/1710-1492-9-42
Laroche D, Chollet S, Léturgie P, Malzac L, Vergnaud MC, Neukirch C, et al. Evaluation of a new routine diagnostic test for immunoglobulin e sensitization to neuromuscular blocking agents. Anesthesiology. 2011;114(1):91-97. DOI: 10.1097/ALN.0b013e31820164d2
Conte B, Zoric L, Bonada G, Debaene B, Ripart J. Reversal of a rocuronium-induced grade IV anaphylaxis via early injection of a large dose of sugammadex. Can J Anesth. 2014;61(6):558-562. DOI: 10.1007/s12630-014-0148-3
Farooq K, Hunter J. Neuromuscular blocking agents and reversal agents. Anaesth Intensive Care Med. 2014;15(6):295-299. DOI: 10.1016/j.mpaic.2014.03.011
Mancuso KF, Owen CP, Lissauer J, Merrit CK, Urman RD, Kaye AD. Perioperative analgesia outcomes and strategies. Best Pract Res Clin Anaesthesiol. 2014;28(2):105-115. DOI: 10.1016/j.bpa.2014.04.005
Jitpakdee T, Mandee S. Strategies for preventing side effects of systemic opioid in postoperative pediatric patients. Paediatr Anaesth. 2014;24(6):561-568. DOI: 10.1111/pan.12420
Redan J, Wells T, Reeder S, et al. No pain, lots of gain: a method to reduce opioid adverse events in your hospital. J Am Coll Surg. 2014;219(4):e100-e101.
Praveen K. Miller’s Anesthesia, volumes 1 and 2, 7th edition. Anesthesiol. 2010;112(1):260-261. DOI: 10.1097/ALN.0b013e3181c5dc06
Butterworth J, Mackey D, Wasnick J. Morgan and Mikhail’s Clinical Anesthesiology. EE. UU.: McGraw-Hill Education; 2006.
Kuruvilla M, Khan D. Anaphylaxis to drugs. Immunol Allergy Clin North Am. 2015;35(2):303-319. DOI: 10.1016/j.iac.2015.01.008
Willsie SK, Evashenk MA, Hamel LG, Hwang SS, Chiang YK, Palmer PP. Pharmacokinetic properties of single-and repeated-dose sufentanil sublingual tablets in healthy volunteers. Clin Ther. 2015;37(1):145-155. DOI: 10.1016/j.clinthera.2014.11.001
Rhyee C, Bienia L, Collins A. Allergies to analgesic medications in ED patients. Am J Emerg Med. 2013;31(2):431-432.
Baldo B, Pham NH. Histamine-releasing and allergenic properties of opioid analgesic drugs: resolving the two. Anaesthe Intensive Care. 2012;40(2):216-235. DOI: 10.1177/0310057X1204000204
Steigelman DA, Rose D, Gomez RA, Rans TS. IgE specific to oxycodone identified by ELISA inhibition in a young woman with symptoms of anaphylaxis following oral ingestion: first case report of oxycodone-mediated anaphylaxis. J Allergy Clin Immunol. 2013;131(2):AB216. DOI: 10.1016/j.jaci.2012.12.1441
Van Gasse AL, Hagendorens M, Sabato V, et al. IgE to poppy seed and morphine are not useful tools to diagnose opiate allergy. J Allergy Clin Immunol Pract. 2015;3(3):396-399. DOI: 10.1016/j.jaip.2014.12.002
Armentia A, Pineda F, Martín-Armentia B, Palacios R. A useful method to detect opioid allergies. J Allergy Clin Inmunol Pract. 2015;3(5):829-830. DOI: 10.1016/j.jaip.2015.05.031
Fung T, Pond D. Risks for patient-controlled analgesia adverse events in opioid-naive patients. J Pain. 2014;4(15):S93.
Celebioglu E, Karakaya G, Kalyoncu A. The safety of codeine in patients with non-steroidal anti-inflammatory drug hypersensitivity: a preliminary study. Allergol Immunopathol (Madr). 2013;41(3):163-168. DOI: 10.1016/j.aller.2012.04.010.
Bounes V, Barniol C, Minville V, Houze-Cerfon CH, Ducassé JL. Predictors of pain relief and adverse events in patients receiving opioids in a prehospital setting. Am J Emerg Med. 2011;29(5):512-517. DOI: 10.1016/j.ajem.2009.12.005
Kiang T, Ensom M. Clinically significant interactions with opioid analgesics. En: Jann M, Penzak S, Cohen L (editors). Applied clinical pharmacokinetics and pharmacodynamics of psychopharmacological agents. EE. UU.: Adis; 2016.
Yiannakopoulou E. Pharmacogenomics and opioid analgesics: clinical implications. Int J Genomics. 2015;2015:368979. DOI: 10.1155/2015/368979
Jannetto PJ, Bratanow NC. Pharmacogenomic considerations in the opioid management of pain. Genome Med. 2010;2(9):66. DOI: 10.1186/gm187
Wltermann K, Geier J, Diessenbacher P, Schadendorf D, Hillen U. Systemic allergic contact dermatitis from intravenous piritramide. Allergy. 2010;65(9):1196-1204. DOI: 10.1111/j.1398-9995.2010.02331.x
Oosten AW, Oldenmenger WH, Mathijssen RH, van der Rijt CC. A systematic review of prospective studies reporting adverse events of commonly used opioids for cancer-related pain: a call for the use of standardized outcome measures. J Pain. 2015;16(10):935-946. DOI: 10.1016/j.jpain.2015.05.006
Sein M, Chen L. Opioid-induced hyperalgesia: the primary care physician’s perspective. J Pain. 2013;14(4):S5. DOI: 10.1016/j.jpain.2013.01.031
Armentia A, Ruiz-Muñoz P, Quesada JM, Postigo I, Herrero M, Martín-Gil FJ, et al. Clinical value of morphine, pholcodine and poppy seed IgE assays in drug-abusers and allergic people. Allergol Immunopathol (Madr). 2013;41(1):37-44. DOI: 10.1016/j.aller.2011.05.011
Nasser SM, Ewan PW. Opiate-sensitivity: clinical characteristics and the role of skin prick testing. Clin Exp Allergy. 2001;31(7):1014-1020. DOI: 10.1046/j.1365-2222.2001.01090.x
Uyttebroek AP, Sabato V, Bridts C. In vitro diagnosis of immediate IgE-mediated drug hypersensitivity: warnings and (unmet) needs. Immunol Allergy Clin North Am. 2014;34(3):681-689. DOI: 10.1016/j.iac.2014.04.007
García-Ortega P, Marín A. Usefulness of the basophil activation test (BAT) in the diagnosis of life-threatening drug anaphylaxis. Allergy. 2010;65(9):1204-1204. DOI: 10.1111/j.1398-9995.2010.02333.x
Samala RV, Bloise R, Davis MP. Efficacy and safety of a six-hour continuous overlap method for converting intravenous to transdermal fentanyl in cancer pain. J Pain Symptom Manage. 2014;48(1):132-136. DOI: 10.1016/j.jpainsymman.2013.09.001
Franck N, Thibaut F. Farmacología y modo de acción de los neurolépticos. Psiquiatria. 2006;37(860):10. DOI: 10.1016/S1634-2151(06)45711-8.
Katzung BG, Masters SB, Trevor AJ. Basic and clinical pharmacology. EE. UU.: McGraw Hill Medical; 2007.
Velasco A. Farmacología clínica y terapéutica médica. Colombia: McGraw Hill/Interamericana; 2004.
Greenier E, Lukyanova V, Reede L. Serotonin syndrome: fentanyl and selective serotonin reuptake inhibitor interactions. AANA J. 2014;82(5):340-345.
Szakaly, B. Strauss R. Serotonin syndrome in the oral and maxillofacial surgery office: a review of the literature and report of a case. J Oral Maxillofac Surg. 2008;66(9):1949-1952. DOI: 10.1016/j.joms.2008.01.016
Muzyk AJ, Cvelich RG, Kincaid BR, Preud’homme XA. Angioedema occurring in patient prescribed iloperidone and haloperidol: a cross-sensitivity reaction to antipsychotics from different chemical classes. J Neuropsychiatry Clin Neurosci. 2012;24(2):E40-E41. DOI: 10.1176/appi.neuropsych.11040094
Verdura-Vizcaíno EJ, Ballesteros-Sanz D, Sanz-Fuentenebro J. Electroconvulsive therapy as treatment for malignant neuroleptic syndrome. Rev Psiquiatr Salud Ment. 2012;4(3):169-176. DOI: 10.1016/j.rpsm.2011.04.005
Perkins J, Ho JD, Vilke GM, DeMers G. American Academy of Emergency Medicine position statement: safety of droperidol use in the emergency department. J Emerg Med. 2015;49(1):91-97. DOI: http://dx.doi.org/10.1016/j.jemermed.2014.12.024
Richards JR, Richards IN, Ozery G, Derlet RW. Droperidol analgesia for opioid-tolerant patients. J Emerg Med. 2011;41(4):389-396. DOI: 10.1016/j.jemermed.2010.07.005
Ambulkar RP, Patil VP, Moiyadi AV. Neuroleptic malignant syndrome: a diagnostic challenge. J Anaesthesiol Clin Pharmacol. 2012;28(4):517-519. DOI: 10.4103/0970-9185.101946
Attri J, Bala N, Chatrath V. Psychiatric patient and anaesthesia. Indian J Anaesth. 2012;56(1):8-13. DOI: 10.4103/0019-5049.93337
Ergin M, Cander B, Girişgin S, Kocak S, Acar T, Gul M. A serious side effect of antipsychotic therapy: neuroleptic malign syndrome. Akad Acil Tip Olgu Sunumlari Derg. 2012;3(3):83-85. DOI: 10.5505/jaemcr.2012.28247
Celis-Rodríguez E, Birchenall C, De-La-Cal MÁ, Castorena-Arellano G, Hernández A, Ceraso D, et al. Clinical practice guidelines for evidence-based management of sedoanalgesia in critically ill adult patients. Med Intensiva. 2013;37(8):519-574. DOI: 10.1016/j.medin.2013.04.001.
Shaikh S, Verma H. Parkinson’s disease and anaesthesia: a review article. Internet J Anesthesiol. 2010;24:32.
Shaikh S, Verma H. Parkinson’s disease and anaesthesia. Indian J Anaesth. 2011;55(3):228-235. DOI: 10.4103/0019-5049.82658
Strawn JR, Keck PE, Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry. 2007;164(6):870-876. DOI: 10.1176/appi.ajp.164.6.870
Ozkardesler S, Gurpinar T, Akan M, Koca U, Sarikaya H, Olmez T, et al. A possible perianesthetic serotonin syndrome related to intrathecal fentanyl. J Clin Anesth. 2008;20(2):143-145. DOI: 10.1016/j.jclinane.2007.06.024
Wilson L, Rooney T, Baugh R, Millington B. Recognition and management of perioperative serotonin syndrome. Am J Otolaryngol. Am J Otolaryngol. 2012;33(3):319-321. DOI: 10.1016/j.amjoto.2011.10.002
Beatty NC, Nicholson WT, Langman LJ, Curry TB, Eisenach JH. Pharmacogenetic workup of perioperative serotonin syndrome. J Clin Anesth. 2013;25(8):662-665. DOI: 10.1016/j.jclinane.2013.06.005
Isbister GK, Buckley NA, Whyte IM. Serotonin toxicity: a practical approach to diagnosis and treatment. Med J Aust. 2007;187(6):361-365. DOI: 10.2174/157489007779606077
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial 4.0.
Derechos de autor 2019 Revista Alergia México